Vinay Prasad, MD, MPH, policy research and oncologist, dissects with me the theory of “value-based care.” How can this concept be used as a tool to better patient care and lower the cost of cancer therapies? Are current value estimations useful in this space?
How do we define value? I think it’s in the eyes of the beholder. Let’s hear what Dr. Prasad has to say. Vinay is very vocal and will not shy away in this episode from describing his views.
Dr Prasad’s podcast “Plenary Session” can be found here. This podcast is produced by the Journal of Clinical Pathways.
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
